5 Stocks Underperforming Today In The Health Services Industry

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 11 points (0.1%) at 15,533 as of Tuesday, July 30, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,505 issues advancing vs. 1,392 declining with 116 unchanged.

The Health Services industry currently sits up 1.0% versus the S&P 500, which is up 0.2%. On the negative front, top decliners within the industry include Express Scripts ( ESRX), down 2.3%, UnitedHealth Group ( UNH), down 0.8% and Cigna ( CI), down 0.6%. A company within the industry that increased today was CareFusion ( CFN), up 1.3%.

TheStreet would like to highlight 5 stocks pushing the industry lower today:

5. Fresenius Medical Care AG & Co. KGaA ( FMS) is one of the companies pushing the Health Services industry lower today. As of noon trading, Fresenius Medical Care AG & Co. KGaA is down $0.78 (-2.4%) to $31.40 on average volume. Thus far, 105,377 shares of Fresenius Medical Care AG & Co. KGaA exchanged hands as compared to its average daily volume of 215,500 shares. The stock has ranged in price between $31.00-$31.48 after having opened the day at $31.43 as compared to the previous trading day's close of $32.18.

Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, operates in the field of dialysis care and dialysis products for the treatment of end-stage renal disease. Fresenius Medical Care AG & Co. KGaA has a market cap of $19.6 billion and is part of the health care sector. Shares are down 6.2% year to date as of the close of trading on Monday. Currently there are 4 analysts that rate Fresenius Medical Care AG & Co. KGaA a buy, no analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates Fresenius Medical Care AG & Co. KGaA as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Fresenius Medical Care AG & Co. KGaA Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, Health Management Associates ( HMA) is down $1.63 (-10.9%) to $13.29 on heavy volume. Thus far, 34.8 million shares of Health Management Associates exchanged hands as compared to its average daily volume of 6.1 million shares. The stock has ranged in price between $13.00-$13.66 after having opened the day at $13.64 as compared to the previous trading day's close of $14.92.

Health Management Associates, Inc., through its subsidiaries, engages in the operation of general acute care hospitals and other health care facilities in non-urban communities in the United States. Health Management Associates has a market cap of $3.9 billion and is part of the health care sector. Shares are up 60.1% year to date as of the close of trading on Monday. Currently there are 8 analysts that rate Health Management Associates a buy, 1 analyst rates it a sell, and 11 rate it a hold.

TheStreet Ratings rates Health Management Associates as a hold. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, solid stock price performance and notable return on equity. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, poor profit margins and weak operating cash flow. Get the full Health Management Associates Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, Humana ( HUM) is down $1.04 (-1.1%) to $89.60 on light volume. Thus far, 404,756 shares of Humana exchanged hands as compared to its average daily volume of 1.5 million shares. The stock has ranged in price between $88.86-$91.33 after having opened the day at $91.14 as compared to the previous trading day's close of $90.64.

Humana Inc., a health care company, offers a range of insurance products, and health and wellness services that incorporate an integrated approach to lifelong well-being. The company operates in three segments: Retail, Employer Group, and Healthcare Services. Humana has a market cap of $14.1 billion and is part of the health care sector. Shares are up 32.1% year to date as of the close of trading on Monday. Currently there are 12 analysts that rate Humana a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and attractive valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Humana Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, WellPoint ( WLP) is down $0.36 (-0.4%) to $85.18 on average volume. Thus far, 1.0 million shares of WellPoint exchanged hands as compared to its average daily volume of 1.9 million shares. The stock has ranged in price between $84.44-$86.52 after having opened the day at $86.00 as compared to the previous trading day's close of $85.54.

WellPoint, Inc., a health benefits company, through its subsidiaries, offers network-based managed care plans to large and small employer, individual, Medicaid, and senior markets in the United States. The company operates through three segments: Commercial, Consumer, and Other. WellPoint has a market cap of $25.3 billion and is part of the health care sector. Shares are up 40.4% year to date as of the close of trading on Monday. Currently there are 7 analysts that rate WellPoint a buy, 1 analyst rates it a sell, and 10 rate it a hold.

TheStreet Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full WellPoint Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Boston Scientific ( BSX) is down $0.09 (-0.8%) to $10.88 on average volume. Thus far, 10.0 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 18.8 million shares. The stock has ranged in price between $10.84-$11.02 after having opened the day at $11.00 as compared to the previous trading day's close of $10.97.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $14.8 billion and is part of the health care sector. Shares are up 91.3% year to date as of the close of trading on Monday. Currently there are 4 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates Boston Scientific as a hold. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, solid stock price performance and impressive record of earnings per share growth. However, as a counter to these strengths, we find that the company has favored debt over equity in the management of its balance sheet. Get the full Boston Scientific Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices